Haemonetics | HAE - تكلفة المبيعات

سعر السهم
59.60
التغيير اليومي
-0.49 -0.82%
شهريا
4.87%
سنويا
-6.66%
Q2 التوقعات
58.65




تكلفة المبيعات تغيير تاريخ
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Cerus USD 23.42M 3.61M 2024-12
Cooper Companies USD 376.8M 87.4M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.68B 38.37M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 197.08M 1.5M 2026-03
Neogen USD 112.2M 5.81M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Quidel USD 448.8M 1.21B 2025-12
ResMed USD 551.67M 4.17M 2026-03
STAAR Surgical USD 14.06M 2.8M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.36B 325M 2026-03
Surmodics USD 9.49M 23.54M 2025-06
Teleflex USD 261.54M 199.84M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
US Physical Therapy USD 160.86M 2.63M 2025-12
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03